Shares of Eastman Kodak (NYSE: KODK) are up two-thirds so far this week after a special committee set up by the company’s board found no lawbreaking in controversial stock trades made by top management in the leadup to announcing a $765 million federal government loan to support a shift to pharmaceutical manufacturing. CEO Jim Continenza…
Kodak stock down 30% after pharma deal put on hold
Shares of Eastman Kodak (NYSE: KODK) were down more than 30% near the close of trading today after a tweet from the U.S. International Development Finance Corp. said a $765 million loan for domestic pharmaceutical manufacturing is on hold. The Aug. 7 tweet said: “On July 28, we signed a Letter of Interest with Eastman…